More on CRISPR Therapeutics CRISPR Therapeutics: Unfairly Punished By The Issues Of Its Peers CRISPR Therapeutics AG (CRSP) 43rd Annual JPMorgan Healthcare Conference - (Transcript) Crispr Therapeutics: From Casgevy Success To A Catalyst-Rich 2025 SA Asks: Which Big Pharmas are likely to announce big M&A deals? Vertex reports positive long-term data for Casgevy